Children and Young People's Gender Incongruence Services

The provision for the the reconfiguration of specialised services for children and young people with gender incongruence, in line with the recommendations of the independent Cass Review. This work necessitates the decommissioning of the current Gender Identity Development Service at the Tavistock and Portman NHS Foundation Trust (Tavistock) by March 2024, and the establishment of two new services from April 2024 in the North-West. The new services, which form Phase 1 of the establishment of up to seven new regional services by 2025/26, will be delivered by provider collaboratives through a lead provider arrangement with:

North-West: Alder Hey Children's Hospital NHS Foundation Trust (lead provider); Manchester University NHS Foundation Trust Additional information: NHS England will directly contract with the related endocrine clinics that are currently sub-contracted directly by the Leeds Teaching Hospitals NHST. This arrangement will be in place for 2024/25 and 2025/26 while the new service model is stabilised, and pending the development of a new service specification for Specialised Paediatric Endocrinology Services by the National Programme of Care for Women and Children, for adoption in 2025/26. Thereafter the planning assumption is that the new regional providers (Phase 1 and Phase 2) may contract directly with local paediatric endocrinology services to establish an integrated pathway.

The provision of the reconfiguration of specialised services for children and young people with gender incongruence, in line with the recommendations of the independent Cass Review. This work necessitates the decommissioning of the current Gender Identity Development Service at the Tavistock and Portman NHS Foundation Trust (Tavistock) by March 2024, and the establishment of new services from April 2024 in London with

London: Great Ormond Street Hospital for Children NHS Foundation Trust (lead provider); South London and Maudsley NHS Foundation Trust; Guys and St Thomas' Hospitals NHS Foundation Trust Additional information: NHS England will directly contract with the related endocrine clinics that are currently sub-contracted directly by the Tavistock - University College London Hospitals NHSFT. This arrangement will be in place for 2024/25 and 2025/26 while the new service model is stabilised, and pending the development of a new service specification for Specialised Paediatric Endocrinology Services by the National Programme of Care for Women and Children, for adoption in 2025/26. Thereafter the planning assumption is that the new regional providers (Phase 1 and Phase 2) may contract directly with local paediatric endocrinology services to establish an integrated pathway.